• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛患者的治疗偏好:离散选择实验。

Chronic pain patients' treatment preferences: a discrete-choice experiment.

机构信息

IGM Institute Health Economics and Healthcare Management, Hochschule Neubrandenburg, Brodaer Straße 2, 17033, Neubrandenburg, Germany,

出版信息

Eur J Health Econ. 2015 Jul;16(6):613-28. doi: 10.1007/s10198-014-0614-4. Epub 2014 Jun 21.

DOI:10.1007/s10198-014-0614-4
PMID:24950770
Abstract

OBJECTIVE

The objective of this study was to identify, document, and weight attributes of a pain medication that are relevant from the perspective of patients with chronic pain. Within the sub-population of patients suffering from "chronic neuropathic pain", three groups were analyzed in depth: patients with neuropathic back pain, patients with painful diabetic polyneuropathy, and patients suffering from pain due to post-herpetic neuralgia. The central question was: "On which features do patients base their assessment of pain medications and which features are most useful in the process of evaluating and selecting possible therapies?"

METHODS

A detailed literature review, focus groups with patients, and face-to-face interviews with widely recognized experts for pain treatment were conducted to identify relevant treatment attributes of a pain medication. A pre-test was conducted to verify the structure of relevant and dominant attributes using factor analyses by evaluating the most frequently mentioned representatives of each factor. The Discrete-Choice Experiment (DCE) used a survey based on self-reported patient data including socio-demographics and specific parameters concerning pain treatment. Furthermore, the neuropathic pain component was determined in all patients based on their scoring in the painDETECT(®) questionnaire. For statistical data analysis of the DCE, a random effect logit model was used and coefficients were presented.

RESULTS

A total of 1,324 German patients participated in the survey, of whom 44 % suffered from neuropathic back pain (including mixed pain syndrome), 10 % complained about diabetic polyneuropathy, and 4 % reported pain due to post-herpetic neuralgia. A total of 36 single quality aspects of pain treatment, detected in the qualitative survey, were grouped in 7 dimensions by factor analysis. These 7 dimensions were used as attributes for the DCE. The DCE model resulted in the following ranking of relevant attributes for treatment decision: "no character change", "less nausea and vomiting", "pain reduction" (coefficient: >0.9 for all attributes, "high impact"), "rapid effect", "low risk of addiction" (coefficient ~0.5, "middle impact"), "applicability with comorbidity" (coefficient ~0.3), and "improvement of quality of sleep" (coefficient ~0.25). All attributes were highly significant (p < 0.001).

CONCLUSIONS

The results were intended to enable early selection of an individualized pain medication. The results of the study showed that DCE is an appropriate means for the identification of patient preferences when being treated with specific pain medications. Due to the fact that pain perception is subjective in nature, the identification of patients´ preferences will enable therapists to better develop and implement patient-oriented treatment of chronic pain. It is therefore essential to improve the therapists´ understanding of patient preferences in order to make decisions concerning pain treatment. DCE and direct assessment should become valid instruments to elicit treatment preferences in chronic pain.

摘要

目的

本研究旨在从慢性疼痛患者的角度确定、记录和权衡疼痛药物的相关属性。在患有“慢性神经性疼痛”的亚人群中,深入分析了三组:神经性背痛患者、患有痛性糖尿病多发性神经病的患者和患有疱疹后神经痛的患者。核心问题是:“患者基于哪些特征来评估疼痛药物,哪些特征在评估和选择可能的治疗方法过程中最有用?”

方法

通过详细的文献回顾、患者焦点小组和广泛认可的疼痛治疗专家的面对面访谈,确定疼痛药物的相关治疗属性。通过评估每个因素中最常提到的代表来进行因子分析,进行预测试以验证相关和主导属性的结构。离散选择实验(DCE)使用基于自我报告的患者数据的调查,包括社会人口统计学和特定的疼痛治疗参数。此外,所有患者的神经性疼痛成分均根据其在疼痛 DETECT(®)问卷中的评分确定。对于 DCE 的统计数据分析,使用随机效应对数模型并呈现系数。

结果

共有 1324 名德国患者参与了调查,其中 44%患有神经性背痛(包括混合疼痛综合征),10%抱怨患有糖尿病多发性神经病,4%报告患有疱疹后神经痛。通过定性调查检测到的 36 个疼痛治疗单一质量方面通过因子分析分为 7 个维度。这 7 个维度被用作 DCE 的属性。DCE 模型得出了以下用于治疗决策的相关属性排序:“无性格变化”、“恶心和呕吐较少”、“疼痛减轻”(系数:所有属性均>0.9,“高影响”)、“快速起效”、“低成瘾风险”(系数0.5,“中影响”)、“伴有合并症的适用性”(系数0.3)和“改善睡眠质量”(系数~0.25)。所有属性均具有高度显著性(p<0.001)。

结论

这些结果旨在实现早期选择个体化疼痛药物。研究结果表明,DCE 是确定接受特定疼痛药物治疗的患者偏好的适当手段。由于疼痛感知本质上是主观的,因此确定患者的偏好将使治疗师能够更好地为慢性疼痛患者制定和实施以患者为中心的治疗方法。因此,提高治疗师对患者偏好的理解对于做出疼痛治疗决策至关重要。DCE 和直接评估应成为引出慢性疼痛治疗偏好的有效工具。

相似文献

1
Chronic pain patients' treatment preferences: a discrete-choice experiment.慢性疼痛患者的治疗偏好:离散选择实验。
Eur J Health Econ. 2015 Jul;16(6):613-28. doi: 10.1007/s10198-014-0614-4. Epub 2014 Jun 21.
2
Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.分析医生观点与患者偏好:多发性骨髓瘤治疗中的直接评估和离散选择实验。
Eur J Health Econ. 2011 Jun;12(3):193-203. doi: 10.1007/s10198-010-0218-6. Epub 2010 Jan 28.
3
Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.首要目标是降低死亡风险:急性冠脉综合征患者的离散选择实验
Pharmacoeconomics. 2015 Jan;33(1):71-81. doi: 10.1007/s40273-014-0223-1.
4
Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.美国患者对骨关节炎疼痛和慢性下腰痛治疗的偏好:一项离散选择实验。
Osteoarthritis Cartilage. 2020 Sep;28(9):1202-1213. doi: 10.1016/j.joca.2020.06.006. Epub 2020 Jul 8.
5
A protocol for a discrete choice experiment: understanding patient medicine preferences for managing chronic non-cancer pain.用于离散选择实验的方案:了解患者在管理慢性非癌症疼痛方面对药物的偏好。
BMJ Open. 2019 Aug 2;9(8):e027153. doi: 10.1136/bmjopen-2018-027153.
6
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.局部用辣椒素(高浓度)治疗成人慢性神经性疼痛。
Cochrane Database Syst Rev. 2013 Feb 28(2):CD007393. doi: 10.1002/14651858.CD007393.pub3.
7
Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.中国进行的为期 8 周、剂量灵活、双盲、安慰剂对照研究显示,普瑞巴林治疗周围神经性疼痛有效。
Clin Ther. 2011 Feb;33(2):159-66. doi: 10.1016/j.clinthera.2011.02.007. Epub 2011 Mar 27.
8
What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.2型糖尿病口服治疗中什么最重要?一项评估患者偏好的离散选择实验。
Eur J Health Econ. 2016 Dec;17(9):1125-1140. doi: 10.1007/s10198-015-0750-5. Epub 2015 Dec 18.
9
COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment.加拿大、德国、英国和美国普通人群对 COVID-19 疫苗的偏好:离散选择实验。
JMIR Public Health Surveill. 2024 Oct 16;10:e57242. doi: 10.2196/57242.
10
The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.普瑞巴林对糖尿病周围神经病变或疱疹后神经痛相关疼痛性睡眠干扰的影响:九项临床试验综述。
Curr Med Res Opin. 2010 Oct;26(10):2411-9. doi: 10.1185/03007995.2010.516142.

引用本文的文献

1
Identifying Adolescent and Young Adults' Preferences for Oncology Symptom Management Clinical Trial Participation.确定青少年和青年成人对肿瘤症状管理临床试验参与的偏好。
Cancer Nurs. 2025 Apr 15. doi: 10.1097/NCC.0000000000001463.
2
Urban-rural differences in preferences for traditional Chinese medicine services among chronic disease patients: a discrete choice experiment.城乡慢性病患者对中医药服务偏好的差异:一项离散选择实验。
BMC Complement Med Ther. 2024 Oct 14;24(1):369. doi: 10.1186/s12906-024-04659-z.
3
Understanding general practitioners' prescribing choices to patients with chronic low back pain: a discrete choice experiment.

本文引用的文献

1
Patient preferences for HIV/AIDS therapy - a discrete choice experiment.患者对 HIV/AIDS 疗法的偏好 - 离散选择实验。
Health Econ Rev. 2013 May 11;3(1):14. doi: 10.1186/2191-1991-3-14.
2
Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making?患者偏好与医生判断:在医疗决策中是否有区别?
Appl Health Econ Health Policy. 2013 Jun;11(3):163-80. doi: 10.1007/s40258-013-0023-3.
3
The societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costs.
理解全科医生为慢性下背痛患者开处方的选择:离散选择实验。
Int J Clin Pharm. 2024 Feb;46(1):111-121. doi: 10.1007/s11096-023-01649-y. Epub 2023 Oct 26.
4
Preferences of People Living with HIV for Long-Acting Antiretroviral Treatment in Germany: Evidence from a Discrete Choice Experiment.德国艾滋病毒感染者对长效抗逆转录病毒治疗的偏好:来自离散选择实验的证据。
Patient. 2023 Sep;16(5):537-553. doi: 10.1007/s40271-023-00641-y. Epub 2023 Jul 12.
5
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.患者对化脓性汗腺炎管理的偏好:欧洲多国离散选择实验的结果。
Patient. 2023 Mar;16(2):153-164. doi: 10.1007/s40271-022-00614-7. Epub 2023 Jan 11.
6
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.美国疾病预防控制中心 2022 年《疼痛阿片类药物处方临床实践指南》。
MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1.
7
Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review.当前健康相关离散选择实验中偏好异质性会计的实践:系统评价。
Pharmacoeconomics. 2022 Oct;40(10):943-956. doi: 10.1007/s40273-022-01178-y. Epub 2022 Aug 12.
8
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis.中重度骨关节炎治疗的多方法定量获益-风险评估。
Br J Clin Pharmacol. 2022 Aug;88(8):3837-3846. doi: 10.1111/bcp.15309. Epub 2022 Apr 8.
9
Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis.探讨慢性疼痛药物治疗中患者偏好的异质性:一项潜在类别分析。
Eur J Pain. 2022 Mar;26(3):648-667. doi: 10.1002/ejp.1892. Epub 2022 Jan 8.
10
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis.对成瘾的担忧与骨关节炎患者的生活质量较低有关:一项探索性的、真实世界的数据分析。
Qual Life Res. 2022 Jan;31(1):185-191. doi: 10.1007/s11136-021-02907-0. Epub 2021 Jul 5.
德国疼痛的社会负担:与健康相关的生活质量、健康状况和直接医疗成本。
J Med Econ. 2012;15(6):1201-15. doi: 10.3111/13696998.2012.716383. Epub 2012 Aug 10.
4
Validity and Reliability of Willingness-to-Pay Estimates: Evidence from Two Overlapping Discrete-Choice Experiments.支付意愿估计的有效性和可靠性:来自两个重叠离散选择实验的证据。
Patient. 2008 Dec 1;1(4):283-98. doi: 10.2165/1312067-200801040-00010.
5
Things are Looking up Since We Started Listening to Patients: Trends in the Application of Conjoint Analysis in Health 1982-2007.自我们开始倾听患者意见以来,情况有所好转:1982-2007 年联合分析在健康领域的应用趋势。
Patient. 2008 Dec 1;1(4):273-82. doi: 10.2165/01312067-200801040-00009.
6
Prevalence and comorbidity of chronic pain in the German general population.慢性疼痛在德国普通人群中的患病率和共病情况。
J Psychiatr Res. 2012 Apr;46(4):444-50. doi: 10.1016/j.jpsychires.2012.01.001. Epub 2012 Jan 21.
7
Discrete choice experiments in health economics: a review of the literature.健康经济学中的离散选择实验:文献综述。
Health Econ. 2012 Feb;21(2):145-72. doi: 10.1002/hec.1697. Epub 2010 Dec 19.
8
Construal Levels and Psychological Distance: Effects on Representation, Prediction, Evaluation, and Behavior.解释水平与心理距离:对表征、预测、评估及行为的影响
J Consum Psychol. 2007;17(2):83-95. doi: 10.1016/S1057-7408(07)70013-X.
9
A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia.精神分裂症多种治疗目标的患者和精神科医生评估一致性检验。
Health Expect. 2013 Jun;16(2):164-76. doi: 10.1111/j.1369-7625.2011.00704.x. Epub 2011 Jun 14.
10
The impact of pain in patients with polyneuropathy.多发性神经病患者的疼痛影响。
Eur J Pain. 2011 Nov;15(10):1015-22. doi: 10.1016/j.ejpain.2011.04.013. Epub 2011 May 19.